Synthesis of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids as new selective carboxylesterase inhibitors and radical scavengers

Bioorg Med Chem Lett. 2019 Dec 1;29(23):126716. doi: 10.1016/j.bmcl.2019.126716. Epub 2019 Oct 14.

Abstract

A series of 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids was synthesized via dealkylation of ethyl 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoates under the action of a Lewis acid. Under the same conditions, ethyl 2-arylhydrazinylidene-3-oxobutanoates were also found to undergo dealkylation rather than the previously described cyclization into cinnolones. Study of the esterase profile of these compounds showed that trifluoromethyl-containing acids, in contrast to non-fluorinated analogs, were effective and selective inhibitors of carboxylesterase (CES), without substantially inhibiting structurally related cholinesterases (acetylcholinesterase and butyrylcholinesterase). Moreover, both 3-oxo-4,4,4-trifluorobutanoic and 3-oxobutanoic acids having methyl or methoxy substituent in the arylhydrazinylidene fragment showed high antioxidant activity in the ABTS test. Thus, 2-arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acids were found to constitute a new class of effective and selective CES inhibitors that also possess high radical-scavenging activity.

Keywords: 2-Arylhydrazinylidene-3-oxo-4,4,4-trifluorobutanoic acid; 2-Arylhydrazinylidene-3-oxobutanoic acid; ABTS assay; Antioxidant; Carboxylesterase; Dealkylation; Esterase profile.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / pharmacology
  • Antioxidants / therapeutic use*
  • Carboxylesterase / antagonists & inhibitors*
  • Humans
  • Molecular Docking Simulation / methods*

Substances

  • Antioxidants
  • Carboxylesterase